Synopsis
0
CEP/COS
0
JDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
Rampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.
2,2'-Dithio-2,2-Bis (N-Methylbenzamide)
CAS Number : 2527-58-4
End Use API : Axitinib
About The Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hydera...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Neelkanth MineChem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Disintegrants & Superdisintegrants
Granulation
Lubricants & Glidants
Thickeners and Stabilizers
Co-Processed Excipients
Coating Systems & Additives
Film Formers & Plasticizers
Chewable & Orodispersible Aids
Taste Masking
Controlled & Modified Release
Rheology Modifiers
Emulsifying Agents
Parenteral
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
94
PharmaCompass offers a list of Axitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Axitinib manufacturer or Axitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Axitinib manufacturer or Axitinib supplier.
PharmaCompass also assists you with knowing the Axitinib API Price utilized in the formulation of products. Axitinib API Price is not always fixed or binding as the Axitinib Price is obtained through a variety of data sources. The Axitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Axitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Axitinib, including repackagers and relabelers. The FDA regulates Axitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Axitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Axitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Axitinib supplier is an individual or a company that provides Axitinib active pharmaceutical ingredient (API) or Axitinib finished formulations upon request. The Axitinib suppliers may include Axitinib API manufacturers, exporters, distributors and traders.
click here to find a list of Axitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Axitinib DMF (Drug Master File) is a document detailing the whole manufacturing process of Axitinib active pharmaceutical ingredient (API) in detail. Different forms of Axitinib DMFs exist exist since differing nations have different regulations, such as Axitinib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Axitinib DMF submitted to regulatory agencies in the US is known as a USDMF. Axitinib USDMF includes data on Axitinib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Axitinib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Axitinib suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Axitinib Drug Master File in Korea (Axitinib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Axitinib. The MFDS reviews the Axitinib KDMF as part of the drug registration process and uses the information provided in the Axitinib KDMF to evaluate the safety and efficacy of the drug.
After submitting a Axitinib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Axitinib API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Axitinib suppliers with KDMF on PharmaCompass.
A Axitinib written confirmation (Axitinib WC) is an official document issued by a regulatory agency to a Axitinib manufacturer, verifying that the manufacturing facility of a Axitinib active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Axitinib APIs or Axitinib finished pharmaceutical products to another nation, regulatory agencies frequently require a Axitinib WC (written confirmation) as part of the regulatory process.
click here to find a list of Axitinib suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Axitinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Axitinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Axitinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Axitinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Axitinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Axitinib suppliers with NDC on PharmaCompass.
Axitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Axitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Axitinib GMP manufacturer or Axitinib GMP API supplier for your needs.
A Axitinib CoA (Certificate of Analysis) is a formal document that attests to Axitinib's compliance with Axitinib specifications and serves as a tool for batch-level quality control.
Axitinib CoA mostly includes findings from lab analyses of a specific batch. For each Axitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Axitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Axitinib EP), Axitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Axitinib USP).
